Literature DB >> 6630452

Use of enzyme immunoassays and the latex agglutination test to measure the temporal appearance of immunoglobulin G and M antibodies after natural infection or immunization with rubella virus.

J M Meegan, B K Evans, D M Horstmann.   

Abstract

The time course of appearance of antibodies after infection with rubella virus was determined with an immunoglobulin G (IgG) detection enzyme-linked immunosorbent assay, a latex agglutination test, and an IgM detection enzyme-linked immunosorbent assay. In six naturally infected rubella patients and 26 vaccinees, antibodies measured by either the IgG enzyme-linked immunosorbent assay or the latex agglutination test generally appeared in parallel with those detected by the hemagglutination inhibition test. By 28 days after inoculation of live virus vaccine and by 2 days postonset of clinical rubella symptoms caused by natural infection, antibodies were found by the two tests for all individuals. A commercially available enzyme-linked immunosorbent assay kit was used to detect rubella-specific IgM. After natural infection, IgM appeared earlier than IgG, and although IgM titers decreased rapidly postinfection, in four of five patients antibodies were still detectable 40 to 43 days after the onset of clinical symptoms. After vaccine-induced infection, rubella-specific IgM was lower in titer than after natural infection and was detected in only three of seven vaccinees 70 days post-immunization.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630452      PMCID: PMC270892          DOI: 10.1128/jcm.18.3.745-748.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Enzyme immunoassays for viral diseases.

Authors:  D E Bidwell; A Bartlett; A Voller
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

2.  Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.

Authors:  P L Ogra; D Kerr-Grant; G Umana; J Dzierba; D Weintraub
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

3.  Detection of antibody to rubella virus by enzyme-linked immunosorbent assay.

Authors:  M Gravell; P H Dorsett; O Gutenson; A C Ley
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

4.  Comparison of an enzyme-linked immunosorbent assay with indirect hemagglutination and hemagglutination inhibition for determination of rubella virus antibody: evaluation of immune status with commercial reagents in a clinical laboratory.

Authors:  A L Truant; B L Barksdale; T W Huber; L B Elliott
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

5.  Persistence of specific IgM after natural infection with rubella virus.

Authors:  J R Pattison
Journal:  Lancet       Date:  1975-01-25       Impact factor: 79.321

6.  Measurement of rubella antibody by hemagglutination inhibition. II. Characteristics of an improved HAI test employing a new method for the removal of non-immunoglobulin HA inhibitors from serum.

Authors:  H Liebhaber
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

7.  Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1976-04

8.  A simple method for detecting antibodies to rubella.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1975-08

9.  Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.

Authors:  W Al-Nakib; J M Best; J E Banatvala
Journal:  Lancet       Date:  1975-01-25       Impact factor: 79.321

10.  Solid-phase radioimmunoassay of rubella virus immunoglobulin M antibodies: comparison with sucrose density gradient centrifugation test.

Authors:  O H Meurman; M K Viljanen; K Granfors
Journal:  J Clin Microbiol       Date:  1977-03       Impact factor: 5.948

View more
  6 in total

1.  Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter.

Authors:  W Dimech; A Bettoli; D Eckert; B Francis; J Hamblin; T Kerr; C Ryan; I Skurrie
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

Review 2.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

3.  Comparison of a latex agglutination test with five other methods for determining the presence of antibody against cytomegalovirus.

Authors:  D G Beckwith; D C Halstead; K Alpaugh; A Schweder; D A Blount-Fronefield; K Toth
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

4.  Differences in antibody responses with rapid agglutination tests for the detection of rubella antibodies.

Authors:  M A Chernesky; D J DeLong; J B Mahony; S Castriciano
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

5.  Comparison of enzyme-linked immunosorbent assay, hemagglutination inhibition, and passive latex agglutination for determination of rubella immune status.

Authors:  R S Steece; M S Talley; M R Skeels; G A Lanier
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

6.  Clinical evaluation of the sensitivity and specificity of a commercially available enzyme immunoassay for detection of rubella virus-specific immunoglobulin M.

Authors:  M A Chernesky; L Wyman; J B Mahony; S Castriciano; J T Unger; J W Safford; P S Metzel
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.